Patent details

EP3631454 Title: TREATMENT OF LAG-3 POSITIVE TUMORS

Basic Information

Publication number:
EP3631454
PCT Application Number:
US2018035134
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187350095
PCT Publication Number:
WO2018222718
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF LAG-3 POSITIVE TUMORS
French Title of Invention:
TRAITEMENT DE TUMEURS POSITIVES POUR LAG-3
German Title of Invention:
BEHANDLUNG VON LAG-3-POSITIVEN TUMOREN
SPC Number:

Dates

Filing date:
30/05/2018
Grant date:
13/09/2023
EP Publication Date:
08/04/2020
PCT Publication Date:
06/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/09/2023
EP B1 Publication Date:
13/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/05/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/09/2023
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
25/09/2023
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
LONBERG, Nils
Address:
United States (US)

2

Name:
LOCKE, Darren
Address:
United States (US)

3

Name:
COGSWELL, John P.
Address:
United States (US)

4

Name:
JACKSON, Jeffrey
Address:
United States (US)

5

Name:
NOVOTNY, James Jr.
Address:
United States (US)

6

Name:
HEDVAT, Cyrus
Address:
United States (US)

7

Name:
CLYNES, Raphael
Address:
United States (US)

8

Name:
HARBISON, Christopher
Address:
United States (US)

9

Name:
EDWARDS, Robin
Address:
United States (US)

Priority

1

Priority Number:
201762512648 P
Priority Date:
30/05/2017
Priority Country:
United States (US)

2

Priority Number:
201762513813 P
Priority Date:
01/06/2017
Priority Country:
United States (US)

3

Priority Number:
201762555176 P
Priority Date:
07/09/2017
Priority Country:
United States (US)

4

Priority Number:
201762582178 P
Priority Date:
06/11/2017
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/574; A61K 39/395; A61K 39/00; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202337
Publication date:
13/09/2023
Description:
Grant (B1)

2

Issue number:
202429
Publication date:
17/07/2024
Description:
Opposition procedure started

3

Issue number:
202429
Publication date:
17/07/2024
Description:
Opposition procedure started

4

Issue number:
202428
Publication date:
10/07/2024
Description:
Opposition procedure started

5

Issue number:
202342
Publication date:
18/10/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
26/09/2023 Power Of Attorney 1
26/09/2023 Outgoing Correspondence 1